The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities

Diabetologia

Volumn 60, Issue 6, 2017, Pages 943-951

  Brunkwall, Louise ^a   Orho Melander, Marju ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

16S sequencing; Faecal microbiome; Genetics; Glycaemic control; Gut microbiome; Metagenomics; Metformin; Personalised nutrition; Probiotics; Review; Type 2 diabetes

Indexed keywords

METFORMIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROPIONIC ACID;

ASCENDING COLON; BARIATRIC SURGERY; DIABETIC DIET; DRUG EFFECT; FECES MICROFLORA; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTESTINE FLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; PASTEURIZATION; PRIORITY JOURNAL; REVIEW; FECES; GENETICS; METABOLISM; MICROBIOLOGY; RADIATION RESPONSE;

DIABETES MELLITUS, TYPE 2; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; METFORMIN;

EID: 85018831116     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4278-3     Document Type: Review

References (52)

1. Jovel J, Patterson J, Wang W et al (2016) Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol 7:459
2. Goodrich JK, Di Rienzi SC, Poole AC et al (2014) Conducting a microbiome study. Cell 158:250–262
3. Falony G, Joossens M, Vieira-Silva S et al (2016) Population-level analysis of gut microbiome variation. Science 352:560–564
4. Zhernakova A, Kurilshikov A, Bonder MJ et al (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:565–569
5. Cani PD, Neyrinck AM, Fava F et al (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50:2374–2383
6. Arora T, Backhed F (2016) The gut microbiota and metabolic disease: current understanding and future perspectives. J Intern Med 280:339–349
7. Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085
8. Zhang X, Shen D, Fang Z et al (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8:e71108
9. Yassour M, Lim MY, Yun HS et al (2016) Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med 8:17
10. Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103
11. Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266
12. Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60
13. Pedersen HK, Gudmundsdottir V, Nielsen HB et al (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535:376–381
14. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453
15. Dao MC, Everard A, Aron-Wisnewsky J et al (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426–436
16. David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–563
17. Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105–108
18. Sonnenburg ED, Sonnenburg JL (2014) Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 20:779–786
19. Tap J, Furet JP, Bensaada M et al (2015) Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol 17:4954–4964
20. Martinez I, Lattimer JM, Hubach KL et al (2013) Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 7:269–280
21. De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696
22. Kovatcheva-Datchary P, Nilsson A, Akrami R et al (2015) Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 22:971–982
23. Napolitano A, Miller S, Nicholls AW et al (2014) Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One 9:e100778
24. Gall WE, Beebe K, Lawton KA et al (2010) α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5:e10883
25. Sekar S, Chandrasekaran A, Rao U, Sastry TP (2011) Comparison of some of the physicochemical characteristics of type 2 diabetic and normal human bones: a sample study. J Diabetes Complicat 25:187–192
26. DeFronzo RA, Buse JB, Kim T et al (2016) Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia 59:1645–1654
27. Buse JB, DeFronzo RA, Rosenstock J et al (2016) The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39:198–205
28. Kaska L, Sledzinski T, Chomiczewska A, Dettlaff-Pokora A, Swierczynski J (2016) Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol 22:8698–8719
29. Evers SS, Sandoval DA, Seeley RJ (2016) The physiology and molecular underpinnings of the effects of bariatric surgery on obesity and diabetes. Annu Rev Physiol 79:313–334
30. Tremaroli V, Karlsson F, Werling M et al (2015) Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22:228–238
31. Lampe JW, Navarro SL, Hullar MA, Shojaie A (2013) Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations. Proc Nutr Soc 72:207–218
32. Korpela K, Flint HJ, Johnstone AM et al (2014) Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One 9:e90702
33. Le Chatelier E, Nielsen T, Qin J et al (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500:541–546
34. Salonen A, Lahti L, Salojarvi J et al (2014) Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8:2218–2230
35. Healey G, Brough L, Butts C, Murphy R, Whelan K, Coad J (2016) Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study. BMJ Open 6:e012504
36. Chambers ES, Viardot A, Psichas A et al (2015) Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64:1744–1754
37. Pingitore A, Chambers ES, Hill T et al (2016) The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab 19:257–265
38. Plovier H, Everard A, Druart C et al (2016) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23:107–113
39. Zhang L, Bahl MI, Roager HM et al (2016) Environmental spread of microbes impacts the development of metabolic phenotypes in mice transplanted with microbial communities from humans. ISME J 11:676–690
40. Goodman AL, Kallstrom G, Faith JJ et al (2011) Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 108:6252–6257
41. Khoruts A, Sadowsky MJ (2016) Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 13:508–516
42. Vrieze A, Van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:913-916 e917
43. Braat H, Rottiers P, Hommes DW et al (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol 4:754–759
44. Chen Z, Guo L, Zhang Y et al (2014) Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J Clin Invest 124:3391–3406
45. Li J, Jia H, Cai X et al (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32:834–841
46. Goodrich JK, Waters JL, Poole AC et al (2014) Human genetics shape the gut microbiome. Cell 159:789–799
47. Goodrich JK, Davenport ER, Beaumont M et al (2016) Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19:731–743
48. Davenport ER, Cusanovich DA, Michelini K, Barreiro LB, Ober C, Gilad Y (2015) Genome-wide association studies of the human gut microbiota. PLoS One 10:e0140301
49. Bonder MJ, Kurilshikov A, Tigchelaar EF et al (2016) The effect of host genetics on the gut microbiome. Nat Genet 48:1407–1412
50. Turpin W, Espin-Garcia O, Xu W et al (2016) Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet 48:1413–1417
51. Power RA, Parkhill J, de Oliveira T (2017) Microbial genome-wide association studies: lessons from human GWAS. Nat Rev Genet 18:41–50
52. Franzosa EA, Hsu T, Sirota-Madi A et al (2015) Sequencing and beyond: integrating molecular ‘omics’ for microbial community profiling. Nat Rev Microbiol 13:360–372